Accendra Health Q1 revenue $627.8M, adj. EBITDA $58.4M; >$1.5B debt optimization

ACCENDRA HEALTH INC/VA/

2026-Q1 EPS reported -$0.08 revenue$627,780,000

Q1 revenue $627.8M (down 6.8% YoY); GAAP loss from cont. ops $6.5M vs $3.8M loss prior year.
Adjusted EBITDA $58.4M vs $96.0M prior year; free cash flow ($2.0M).
Announces comprehensive >$1.5B balance sheet optimization with existing creditors to extend maturities and reduce leverage.
Transaction expected to pay off 2027 maturities, extend revolver, and reduce total leverage.
CEO says transformation into pure-play home-based care company on track; Owens & Minor separation proceeding.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2026 results: revenue $ 627.8, net income $ (6.5), EPS $ (0.08).

Period: the first quarter ended March 31, 2026
Revenue: $ 627.8
Net income: $ (6.5)
EPS: $ (0.08)
Result: reported results

Exact text from the filing

Commission this morning. Details on First Quarter 2026 Results First Quarter Results (1) ($ in millions, except per share data) 1Q26 1Q25 Net Revenue $ 627.8 $ 673.9 Loss from continuing operations, net of tax, GAAP $ (6.5) $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP $ (3.1) $ 23.2

View on SEC.gov

Browse all earnings releases →

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001104659-26-058226

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.